Traitement par cellules CAR (Chimeric antigen receptor)-T en cas de maladie auto-immune sévère : la panacée ?

Rev Med Suisse. 2024 Jun 5;20(877):1139. doi: 10.53738/REVMED.2024.20.877.1139.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Autoimmune Diseases* / immunology
  • Autoimmune Diseases* / therapy
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / methods
  • Receptors, Antigen, T-Cell / immunology
  • Receptors, Chimeric Antigen* / immunology
  • Severity of Illness Index
  • T-Lymphocytes / immunology

Substances

  • Receptors, Chimeric Antigen
  • Receptors, Antigen, T-Cell